What is Verility?
Verility, LLC is at the forefront of revolutionizing animal health by developing advanced technologies for breeding and fertility. Their flagship product, FERTILE-EYEZ, leverages image recognition and artificial intelligence to streamline sperm analysis and ovulation detection. This mobile solution offers a more accessible and efficient alternative to traditional methods, aiming to boost conception rates and positively impact the global food supply chain. By addressing the limitations of existing technologies, Verility is poised to become a key player in the animal health sector.
How much funding has Verility raised?
Verility has raised a total of $3.6M across 2 funding rounds:
Series A
$3.5M
Debt
$150K
Series A (2022): $3.5M with participation from Mountain Group Partners
Debt (2026): $150K, investors not publicly disclosed
Key Investors in Verility
Mountain Group Partners
Mountain Group Partners is a venture capital firm specializing in early-stage Life Sciences, AgTech, and Technology investments. They are known for their hands-on approach and long-term commitment to shaping companies from inception.
What's next for Verility?
With its recent strategic investment, Verility is positioned for accelerated growth and further development of its AI-driven fertility solutions. The company is likely to expand its market reach, enhance its product offerings, and potentially explore new applications within the animal health industry. This funding will be instrumental in scaling operations and solidifying Verility's role as an innovator in improving animal reproductive efficiency.
See full Verility company page
